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A B S T R A C T
The aim of this retrospective study was to assess the incidence and aetiology of central and peripheral
venous catheter (C/PVC) infections during a 2-year period (1999–2000) and to determine the
susceptibility of isolated microorganisms to various antimicrobial agents. Catheter tips were processed
using the semiquantitative method and blood cultures were performed with the BacT/Alert automated
system. Antibiotic susceptibilities were performed by disk agar diffusion and MICs were determined by
Etest, according to NCCLS standards. During the study period, samples from 1039 C/PVC infections
were evaluated, yielding 384 (37.0%) positive cultures. Blood cultures were also available from 274
patients, of which 155 (56.6%) yielded the same microorganism as from the catheter. No bloodstream
infections were detected in 104 C/PVC-positive cases. Methicillin-resistant coagulase-negative staphy-
lococci were the most frequent isolates, followed by Gram-negative bacteria, especially Pseudomonas
aeruginosa. Resistance to glycopeptides among staphylococci and enterococci was not detected, whereas
60% of Gram-negative bacilli were resistant to b-lactams.
Keywords Catheter-related bloodstream infections, antibiotic susceptibility
Original submission: 14 November 2002; Revised Submission: 24 April 2003; Accepted: 16 May 2003
Clin Microbiol Infect 2004; 10; 431–435
I N T R O D U C T I O N
The use of intravascular catheters for vascular
access and haemodynamic monitoring has become
a central part of modern medicine [1]. Infections
with significant morbidity and mortality are the
predominant complications associated with the
use of these devices [1,2]. Intravenous catheters are
the commonest cause of hospital-acquired blood-
stream infections [3]. A steady rise in the incidence
of intravascular catheter-associated infections has
been observed, reflecting the increasing role of
catheters in patient management. This has oc-
curred despite emerging evidence-based measures
to reduce infection complications [1,3].
The most recent guidelines of the Centers for
Disease Control and Prevention define a colonised
catheter as one yielding growth of at least 15 CFU
by semiquantitative culture, or > 103 CFU by
quantitative culture from a proximal or distal
catheter without clinical signs of infection [4].
Catheter-related bloodstream infection (CRBSI) is
defined as the isolation of the same organism from
blood culture as from a semiquantitative or quan-
titative catheter culture in the presence of systemic
signs of bloodstream infection and no other appar-
ent source of infection [1,4]. Catheter infection
without bloodstream infection requires systemic
evidence of infection, the presence of at least 15
CFU on the catheter tip, and absence of blood-
stream infection with the organism found on the
catheter tip [1,4].
One major aspect of catheter-related sepsis that
needs to be taken into account in any preventive
strategy is the source of the microorganisms.
Bacteria can gain access to intravascular catheters
by migration from skin at the time of insertion,
via the internal lumen of the device, or by spread
from the skin insertion site along the external
surface [1,4,5]. Two other sources, which are
considered to be relatively minor contributors to
sepsis, are haematogenous spread from other
body sites or from a contaminated infusion [1,3–5].
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Various attempts have been made to quantify the
burden of disease caused by intravascular device-
associated infection. The objective of this retro-
spective study was to determine the incidence of
catheter-related infections, as well as the respon-
sible microorganisms, in a tertiary care teaching
hospital. In addition, the antibiotic susceptibility
profiles during a 2-year period are reported.
M E T H O D S
Setting
The University Hospital of Patras is a 750-bed tertiary care
teaching hospital receiving patients from south-west Greece. It
includes departments of internal medicine, paediatrics, obstet-
rics, cardiology, pulmonary diseases, infectious diseases,
haematology, renal and dermatology, as well as surgery wards
(general, orthopaedic, and neurosurgery), and intensive care
units (ICUs) for adults and neonates. During 1999 and 2000,
the numbers of patients admitted were 52 143 and 54 019,
respectively.
Isolates
During 1999 and 2000, 530 and 509 central and peripheral
venous catheter (C/PVC) tips were received for culture.
Specimens were collected according to clinical signs of catheter
exit-site infection or device-related bloodstream infection in
the absence of other sources [1,3,4]. Patients were hospitalised
in the department of internal medicine, the renal unit, general
surgery, orthopaedics, or the two ICUs. Blood cultures were
also taken from the central venous catheter and/or from a
peripheral venepuncture. Catheter tips were cultured only
when infection was suspected, and were processed using the
semiquantitative method of Maki et al. [6]; using flamed
forceps, the catheter segment was rolled back and forth
at least four times on a 5% blood agar plate and incubated
for 24–48 h at 37 C. Blood cultures were incubated using the
BacT/Alert automated system (bioMe´rieux, Durham, NC,
USA). Blood culture bottles giving a positive reading were
subcultured on to MacConkey and 5% blood agar plates.
Following incubation, isolates were identified to the species
level using standard biochemical methods.
Antibiotic susceptibility testing
Antibiotic susceptibility testing was performed by agar disk
diffusion using antibiotic disks (Becton Dickinson, Cockeys-
ville, MD, USA), selected according to the microorganism
isolated [7]. Etests (AB Biokisk, Solna, Sweden) were used to
determine MICs [8]. Results by both methods were evaluated
according to NCCLS criteria [7,8].
Definitions
Central or peripheral catheter infection without bloodstream
infection (C/PVC-BSI) was defined as systemic evidence of
infection, with the presence of at least 15 CFU on the catheter
tip, but an absence of bacteraemia with the organism isolated
from the catheter. CRBSI required the presence of bacteraemia,
with the organism isolated from the catheter tip present in at
least two additional peripheral blood samples besides those
obtained through the catheter [1,3,4,6].
Statistical analysis
All comparisons were unpaired and determined by the
Students’ t-test with equal or unequal variance. All values
are expressed as a percentage of the group from which they
were derived, with p < 0.05 considered to be significant.
R E S U L T S
Of 1039 catheter tip cultures during the study
period (530 in 1999 and 509 in 2000), 384 (37.0%)
were positive. No blood cultures were available
from 110 patients with positive C/PVC samples,
and these patients were excluded from the study.
Of the remaining 274 cases, 104 (37.9%), 45 in
1999 and 59 in 2000, were C/PVC-BSI, while 155
(56.6%), 69 in 1999 and 86 in 2000, involved
CRBSI. Fifteen more cases (5.5%) were associated
with bacteraemia caused by a different organism
to that isolated from the catheter tip.
Among the CRBSI group, 104 (67.1%) Gram-
positive bacteria were identified. Coagulase-
negative staphylococci (CNS) were recovered
from 92 patients (59.4%). Gram-negative bacteria
were identified from 43 (27.8%) patients, with a
predominance of Pseudomonas aeruginosa (19
patients; 12.3%). Fungi were isolated from eight
patients (5.1%) during the study period (three
isolates in 1999 vs. five in 2000) (Table 1).
Among the 104 patients with C/PVC-BSI,
Gram-positive bacteria were isolated from 63
(60.6%) patients with CNS being the predominant
organisms (n ¼ 50; 48%). Thirty-three (31.7%)
Gram-negative bacteria and eight (7.7%) fungi
were also isolated (one isolate in 1999 vs. seven in
2000) (Table 1). There was no significant differ-
ence in the isolation of Gram-positive or Gram-
negative bacteria between the two groups (CRBSI
and C/PVC-BSI) (p 0.73 for Gram-positive, p 0.65
for Gram-negative; p 0.72 for fungi).
Most CNS were isolated from patients entering
the general surgery and the internal medicine
departments (Table 1). P. aeruginosa was isolated
mainly from the adult ICU, while half of the other
Gram-negative bacilli were recovered from
catheter-related infections at the department of
general surgery (Table 1). Among the CNS
isolated during 1999 and 2000 from patients
with catheter-related infection, 73% and 64%,
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respectively, were resistant to oxacillin. All
staphylococci were sensitive to netilmicin and
glycopeptides (vancomycin and teicoplanin)
(Fig. 1a,b). No vancomycin-resistant Enterococcus
spp. were identified.
Gram-negative bacteria showed high levels of
resistance to b-lactam antibiotics and 5% resist-
ance to imipenem (Fig. 1c). P. aeruginosa showed
high resistance rates to anti-pseudomonal
penicillins- and lower resistance rates to netilmi-
cin and aztreonam (Fig. 1d), while three isolates
were resistant to all antimicrobial agents tested.
D I S C U S S I O N
In the USA, more than half of all hospital
inpatients receive an intravascular catheter,
whereas in Europe the incidence is 63% [1]. In
1998, over 150 million catheters were used in the
USA, and the number of cases of bacteraemia or
fungaemia associated with intravascular catheters
rose to over 400 000 cases annually [2]. Most of
these were associated with central vein catheters.
If there is an attributable mortality of 20%, then
80 000 deaths are associated with intravascular
catheter sepsis annually in the USA alone [2].
Compared to peripheral or arterial catheters,
central venous catheters are associated with a
higher rate of line-associated bacteraemia
(4–14%) [1]. The pathogenesis of intravascular
catheter-associated infection is complex and
begins with attachment and colonisation of either
the outer or inner surface of the catheter by
the infecting microorganism. The outer surface
of the catheter may become colonised with
organisms originating from skin, either by direct
extension from a contiguous infectious process, or
by haematogenous seeding. Alternatively, the
inner surface of the catheter may become colo-
nised by the introduction of organisms through
the catheter hub [1,4].
Once colonisation occurs, the opportunity for
development of infection is present. Although the
relationship between the level of colonisation and
infection is not straightforward, there is good
evidence that the presence of local and blood-
stream infection is related to the number of
microorganisms present on the catheter, as detec-
ted by semiquantitative roll-plate and sonication
methods [6,9]. In our clinical microbiology labor-
atory, the semiquantitative technique was applied
to identify infection of C/PVCs. Of 1039 catheter
tips, 384 (36.9%) were positive during the study
period. One hundred and ten samples were
excluded from the study because of incomplete
evidence of catheter-related infection. There was
no significant difference in the total number of
catheter-related infections between the years 1999
and 2000. However, isolates of Candida spp.
increased from four to 12.
Many studies suggest that the risk of CRBSI is
highly associated with age, site of insertion,
repeated catheterisation, duration of catheterisa-
tion, experience of the person inserting the cath-
eter, absence of antibiotic therapy and underlying
disease (i.e., haematological malignancies, neu-
tropenia, solid tumours, diabetes, haemodialysis,
use of corticosteroids and patients treated in
ICUs) [3]. In our study group, 155 (56.6% of
those who could be evaluated) had CRBSI,
whereas a different microorganism was isolated
in 15 (3.9%) cases. Pelletier et al. reported that
17.6% of bacteraemia cases were associated with
organisms different from those isolated from the
catheter tip, and that an unrelated bacteraemia is
most likely to develop in ICU patients [3].
Table 1. Microorganisms isolated
from intravenous catheter-related





GS IM ICUa ICUn Total (%) GS IM ICUa ICUn Total (%)
CNS 37 34 14 7 92 (59.4) 16 17 16 1 50 (48)
Staphylococcus aureus 1 7 – – 8 (5.1) 1 1 – – 2 (2)
Enterococci 1 3 – – 4 (2.6) 4 3 – – 7 (6.7)
Streptococci – – – – – 1 3 – – 4 (3.9)
Pseudomonas aeruginosa 7 3 9 – 19 (12.3) 4 3 13 – 20 (19.2)
Other
Gram-negativesb
15 3 4 2 24 (15.5) 3 5 4 1 13 (12.5)
Fungi 3 4 – 1 8 (5.1) 2 3 2 1 8 (7.7)
Total (%) 64 (41.3) 54 (34.8) 27 (17.4) 10 (6.5) 155 (100) 31 (29.8) 35 (33.6) 35 (33.6) 3 (3) 104 (100)
aHospital wards: GS: General Surgery; IM: Internal Medicine; ICUa: Intensive Care Unit for adults; ICUn: Intensive
Care Unit for neonates.
bGram-negative bacilli, other than P. aeruginosa.
CNS, coagulase-negative staphylococci; CRBSI, catheter-related bloodstream infection; C/PVC-BSI, central or
peripheral catheter infection without bloodstream infection.
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However, the present study did not identify an
association between these cases and hospitalisa-
tion on a particular ward. In addition, the results
showed no significant differences in the isolation
of Gram-negative or Gram-positive bacteria asso-
ciated with C/PVC-BSI, as compared with CRBSI.
In a study performed during a 3-year period in
the surgery ward of the University Hospital of
Charlottesville, Gram-negative organisms pre-
dominated among patients with CRBSI [3]. As in
the present study, the most frequent isolates
were CNS, and especially methicillin-resistant
Staphylococcus epidermidis strains (Fig. 1a) [3].
S. epidermidis, the commonest species of the nor-
mal human skin microflora, is the predominant
organism isolated from medical devices [10,11].
The adherence of these bacteria to surfaces, the
secretion of an extracellular polysaccharide
(slime), and the formation of biofilm protects the
bacteria from antibiotics and the host immune
system [12–14]. Methicillin resistance, which was
identified in most of our isolates, is associated with
more virulent strains. It has been shown that S.
epidermidis variants lacking mecA expression show
a strongly reduced adherence capacity, offering
further evidence that mecA-positive staphylococci
are associated more often with infectivity than
colonisation among patients [15,16]. In a study
performed in our laboratory, the spread of certain
clones was identified among methicillin-resistant
CNS isolated from catheter infections [17].
P. aeruginosa was the predominant Gram-
negative species isolated, especially from the
ICU patients, and the rate of isolation rose during
2000. Multiresistant strains were also identified,
again with increasing incidence in 2000 (Fig. 1d).
Even though the incidence of CRBSI caused by
Gram-negative bacilli is reported to be lower
than that of Gram-positive bacteria [4,18],
P. aeruginosa, as well as other multiresistant
Gram-negative bacteria (Escherichia coli, Acinetob-
acter spp., Klebsiella pneumonia), has been shown to
cause intravascular catheter-related infections in
several institutions [19–21], as well as in our own
hospital. P. aeruginosa strains are characterised by
their ability to produce an extracellular polysac-
charide (alginate) which enhances bacterial adhe-
sion and survival on catheters or other biomedical
materials [19].
An increasing incidence of intravascular
catheter-associated infections has been observed
worldwide, reflecting the rise in invasive
Fig. 1. Antibiotic resistance patterns of: (a) coagulase-
negative staphylococci, (b) Staphylococcus aureus, (c) Gram-
negative bacilli other than Pseudomonas aeruginosa, and
(d) P. aeruginosa. Ampicillin (Amp), oxacillin (Ox), cefaclor
(Cec), ceftazidime (Caz), ceftriaxone (Cro), amoxycillin with
clavulanic acid (Amc), imipenem (Ipm), ciprofloxacin (Cip),
netilmicin (Net), amikacin (Ak), sulphamethoxazole-
trimethoprim (Sxt), vancomycin (Va), carbenicillin (Cb),
ticarcillin with clavulanic acid (Tim), azlocillin (Az), pip-
eracillin (Pip), aztreonam (Atm).
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procedures. The use of the less expensive semi-
quantitative method for processing catheter tips in
combination with blood cultures may improve
diagnosis of CRBSI. In the present study, methi-
cillin-resistant CNS were the predominant species
isolated, followed by P. aeruginosa. The isolation of
these resistant organisms highlights the need for
new preventative and therapeutic measures.
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